Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 217–217 | Cite as

Nivolumab

Secondary sclerosing cholangitis: case report
Case report
  • 26 Downloads

Reference

  1. Noda-Narita S, et al. Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab. European Journal of Cancer 107: 93-96, Jan 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2018.11.021 - Japan

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations